Evidence map›Paper›PMID 42047307›Full record

ArticleFuture science OA2026

On the mode of anti-

Sachin Gadakh, Teresa Szczepińska, Małgorzata Potoczna, Shiho Okitsu-Sakurayama, Piotr Podlasz, Marta Rogalska, Ewa Kaczorowska, Agnieszka Adamczyk-Woźniak, Monika Staniszewska

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future science OA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sachin GadakhCentre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, Warsaw, Poland.
Teresa SzczepińskaCentre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, Warsaw, Poland.
Małgorzata PotocznaDepartment of Pathophysiology, Forensic Veterinary Medicine and Administration, Faculty of Veterinary Medicine, University of Warmia and Mazury, Olsztyn, Poland.
Shiho Okitsu-SakurayamaDepartment of Pathophysiology, Forensic Veterinary Medicine and Administration, Faculty of Veterinary Medicine, University of Warmia and Mazury, Olsztyn, Poland.
Piotr PodlaszDepartment of Pathophysiology, Forensic Veterinary Medicine and Administration, Faculty of Veterinary Medicine, University of Warmia and Mazury, Olsztyn, Poland.
Marta RogalskaFaculty of Chemistry, Warsaw University of Technology, Warsaw, Poland.
Ewa KaczorowskaFaculty of Chemistry, Warsaw University of Technology, Warsaw, Poland.
Agnieszka Adamczyk-WoźniakFaculty of Chemistry, Warsaw University of Technology, Warsaw, Poland.
Monika StaniszewskaCentre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBenzoxaboroles showed significant antimicrobial efficacy in the past, warranting further investigation. RESEARCH DESIGN AND

methodsBenzoxaboroles were evaluated for their cytotoxicity on Vero E6 and PBMCs, as well as their embryotoxicity in zebrafish embryos. Benzoxaboroles' impact on

resultsBis(benzoxazole) analog (

conclusionsBenzoxaboroles exhibited a similar resistance to azoles, which is associated with increased MDR1 and IDH6 levels. Efflux inhibitors for benzoxaboroles were crucial for treating candidiasis and may inspire future antifungal research.

Indexed as

antifungalsBenzoxaborolesbiofilmcytotoxicityembryotoxicityLeuRSMDRmorphogenesis

Identifiers

PMID42047307
PMCPMC13128027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.